文献速递肥胖与代谢综合征

PPARGC1A rs8192678 位点等位基因替换改变人白色脂肪细胞分化、脂肪生成及 PGC-1α 含量与周转

Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover.
PubMed 文献 · Diabetologia · 2023-05-12

研究采用 CRISPR-Cas9 在等基因人前脂肪细胞系中对 PPARGC1A rs8192678 进行 C-to-T 或 T-to-C 等位基因替换,获得 T/T(Ser482Ser)、C/C(Gly482Gly)和 C/T(Gly482Ser)同源细胞群。分化后 C/C 脂肪细胞 BODIPY 阳性更低、甘油三酯含量显著更低,C 等位基因呈剂量依赖性降低脂肪生成并下调脂肪生成、脂质分解代谢、脂肪合成与脂解关键基因表达。C/C 脂肪细胞基础和最大呼吸氧耗率及 ATP 相关氧耗率降低,效应源于 C 等位基因驱动的 PGC-1α 蛋白含量、周转率和转录共激活活性失调。

要点

  • C/C 脂肪细胞 BODIPY 阳性低于 T/T 和 C/T,甘油三酯含量显著更低。
  • C 等位基因剂量依赖性降低脂肪生成并下调脂肪生成、脂质分解代谢、脂肪合成与脂解关键基因表达。
  • C/C 脂肪细胞基础和最大呼吸氧耗率及 ATP 相关氧耗率降低,与 PGC-1α 蛋白含量、周转率和转录共激活活性失调相关。

核心结论

  • rs8192678 变异对脂肪细胞分化具有等位基因特异性因果效应。
  • C 等位基因导致 PPARGC1A mRNA 和 PGC-1α 蛋白水平降低,并破坏 PGC-1α 周转与活性动态,下游影响细胞分化和线粒体功能。
  • 本研究首次提供 rs8192678 对脂肪细胞表型影响的实验推导见解。

研究设计与样本

  • 采用 CRISPR-Cas9 基因组编辑在等基因人前脂肪细胞白色脂肪组织(hWAs)细胞系中对 rs8192678 进行等位基因替换(C-to-T 或 T-to-C)。
  • 扩增并筛选等位基因编辑的单细胞克隆,获得纯合 T/T(Ser482Ser)、C/C(Gly482Gly)和杂合 C/T(Gly482Ser)等基因细胞群。
  • 随后进行等位基因依赖性效应对白色脂肪细胞分化和线粒体功能影响的功能研究。

主要发现

  • 分化后 C/C 脂肪细胞 BODIPY 阳性肉眼可见低于 T/T 和 C/T 脂肪细胞,且甘油三酯含量显著更低。
  • C 等位基因对脂肪生成呈剂量依赖性降低效应,并降低脂肪生成、脂质分解代谢、脂肪合成和脂解关键基因的表达。
  • C/C 脂肪细胞基础和最大呼吸氧耗率(OCR)降低,ATP 相关 OCR 更低。
  • 上述效应是 C 等位基因驱动 PGC-1α 蛋白含量、周转率和转录共激活活性失调的结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: PPARGC1A encodes peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α), a central regulator of energy metabolism and mitochondrial function. A common polymorphism in PPARGC1A (rs8192678, C/T, Gly482Ser) has been associated with obesity and related metabolic disorders, but no published functional studies have investigated direct allele-specific effects in adipocyte biology. We examined whether rs8192678 is a causal variant and reveal its biological function in human white adipose cells. METHODS: We used CRISPR-Cas9 genome editing to perform an allelic switch (C-to-T or T-to-C) at rs8192678 in an isogenic human pre-adipocyte white adipose tissue (hWAs) cell line. Allele-edited single-cell clones were expanded and screened to obtain homozygous T/T (Ser482Ser), C/C (Gly482Gly) and heterozygous C/T (Gly482Ser) isogenic cell populations, followed by functional studies of the allele-dependent effects on white adipocyte differentiation and mitochondrial function. RESULTS: After differentiation, the C/C adipocytes were visibly less BODIPY-positive than T/T and C/T adipocytes, and had significantly lower triacylglycerol content. The C allele presented a dose-dependent lowering effect on lipogenesis, as well as lower expression of genes critical for adipogenesis, lipid catabolism, lipogenesis and lipolysis. Moreover, C/C adipocytes had decreased oxygen consumption rate (OCR) at basal and maximal respiration, and lower ATP-linked OCR. We determined that these effects were a consequence of a C-allele-driven dysregulation of PGC-1α protein content, turnover rate and transcriptional coactivator activity. CONCLUSIONS/INTERPRETATION: Our data show allele-specific causal effects of the rs8192678 variant on adipogenic differentiation. The C allele confers lower levels of PPARGC1A mRNA and PGC-1α protein, as well as disrupted dynamics of PGC-1α turnover and activity, with downstream effects on cellular differentiation and mitochondrial function. Our study provides the first experimentally deduced insights on the effects of rs8192678 on adipocyte phenotype.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Huang M, Claussnitzer M, Saadat A, et al. Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover. Diabetologia. 2023. PMID: 37171500. doi:10.1007/s00125-023-05915-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。